Yimin Qian

7.9k total citations · 3 hit papers
73 papers, 5.9k citations indexed

About

Yimin Qian is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yimin Qian has authored 73 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 27 papers in Oncology and 16 papers in Hematology. Recurrent topics in Yimin Qian's work include Protein Degradation and Inhibitors (21 papers), Protein Kinase Regulation and GTPase Signaling (20 papers) and Ubiquitin and proteasome pathways (15 papers). Yimin Qian is often cited by papers focused on Protein Degradation and Inhibitors (21 papers), Protein Kinase Regulation and GTPase Signaling (20 papers) and Ubiquitin and proteasome pathways (15 papers). Yimin Qian collaborates with scholars based in United States, China and Switzerland. Yimin Qian's co-authors include Andrew D. Hamilton, Saı̈d M. Sebti, Craig M. Crews, Hanqing Dong, Jiazhi Sun, Andrew P. Crew, Jing Wang, Andreas Vogt, John Hines and Kanak Raina and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Yimin Qian

72 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü, Yimin Qian et al. Chemistry & Biology profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Kanak Raina, Jing Lü et al. profile →
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

2017 488 citations George M. Burslem, Blake E. Smith et al. Cell chemical biology profile →

Peers

Countries citing papers authored by Yimin Qian

Since Specialization

Citations

This map shows the geographic impact of Yimin Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Qian more than expected).

Fields of papers citing papers by Yimin Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yimin Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Qian. The network helps show where Yimin Qian may publish in the future.

Co-authorship network of co-authors of Yimin Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Yimin Qian. A scholar is included among the top collaborators of Yimin Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yimin Qian. Yimin Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rats 2025 ·Drugs in R&D ·Liping Wei, Min Jeong Hong, (unknown), Yimin Qian, Qingmei Li, Naping Tang, Hua Li, Yan Chang, (unknown)	0
2	Integration of conflict resolution and positive emotions: Electrophysiological evidence 2020 ·Neuropsychologia ·(unknown), (unknown), Hui Sun, Yimin Qian	9
3	BETP degradation simultaneously targets acute myelogenous leukemic stem cells and the microenvironment 2019 ·Journal of Clinical Investigation ·Sujan Piya, Hong Mu, Seemana Bhattacharya, Philip L. Lorenzi, R. Eric Davis, Teresa McQueen, Vivian Ruvolo, Natalia Baran, Zhiqiang Wang, Yimin Qian, Craig M. Crews, Marina Konopleva, Jo Ishizawa, M. James You, Hagop M. Kantarjian, Michael Andreeff, Gautam Borthakur	56
4	Targeted Therapy for AML Expressing RUNX1 Mutation 2017 ·Blood ·Christopher P. Mill, Warren Fiskus, Courtney D. DiNardo, Yimin Qian, Kanak Raina, Koichi Takahashi, Tapan M. Kadia, Dyana T. Saenz, Agnieszka Nowak, Baohua Sun, Craig M. Crews, Kapil N. Bhalla	1
5	BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells 2017 ·Leukemia ·Baohua Sun, Warren Fiskus, Yimin Qian, Kimal Rajapakshe, Kanak Raina, Kevin Coleman, Andrew P. Crew, Angela Shen, Dyana T. Saenz, Christopher P. Mill, Agnieszka Nowak, Neeraj Jain, (unknown), M Wang, Joseph D. Khoury, Cristian Coarfa, Craig M. Crews, Kapil N. Bhalla	136
6	The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study breakdown → 2017 ·Cell chemical biology ·George M. Burslem, Blake E. Smith, (unknown), Saul Jaime‐Figueroa, Daniel McQuaid, Daniel P. Bondeson, Momar Toure, Hanqing Dong, Yimin Qian, Jing Wang, Andrew P. Crew, John Hines, Craig M. Crews	488
7	BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825, Causes Sustained Degradation of BRD4 and Modulation of Chemokine Receptors, Cell Adhesion and Metabolic Targets in Leukemia Resulting in Profound Anti-Leukemic Effects 2016 ·Blood ·Sujan Piya, Seemana Bhattacharya, Hong Mu, Philip L. Lorenzi, Teresa McQueen, (unknown), Vivian Ruvolo, Natalia Baran, Yimin Qian, Craig M. Crews, Hagop M. Kantarjian, Michael Andreeff, Gautam Borthakur	8
8	Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 breakdown → 2015 ·Chemistry & Biology ·Jing Lü, Yimin Qian, Martha Altieri, Hanqing Dong, Jing Wang, Kanak Raina, John Hines, James D. Winkler, Andrew P. Crew, Kevin Coleman, Craig M. Crews	849
9	Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yimin Qian, David Bolin, Karin Conde‐Knape, Paul Gillespie, (unknown), Kuo‐Sen Huang, Andrée R. Olivier, Tsutomu Sato, Qing Xiang, Weiya Yun, Xiaolei Zhang	30
10	Potent MCH-1 receptor antagonists from cis-1,4-diaminocyclohexane-derived indane analogs 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yimin Qian, Karin Conde‐Knape, Shawn D. Erickson, Fiorenza Falcioni, Paul Gillespie, (unknown), (unknown), (unknown), (unknown), (unknown), Jefferson Tilley	14
11	Structure-based design of imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase 2006 ·Organic & Biomolecular Chemistry ·Junko Ohkanda, Corey L. Strickland, Michelle A. Blaskovich, (unknown), Jeffrey W. Lockman, Andreas Vogt, (unknown), Jiazhi Sun, Yimin Qian, David B. Knowles, (unknown), Saı̈d Sebti, Andrew D. Hamilton	9
12	Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts 1998 ·Oncogene ·Jiazhi Sun, Yimin Qian, Andrew D. Hamilton, Saı̈d M. Sebti	188
13	Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes. 1998 ·PubMed ·Eric J. Bernhard, W. Gillies McKenna, Andrew D. Hamilton, Saı̈d M. Sebti, Yimin Qian, Junmin Wu, Ruth J. Muschel	154
14	Farnesyltransferase as a target for anticancer drug design 1997 ·Biopolymers ·Yimin Qian, Saı̈d M. Sebti, Andrew D. Hamilton	62
15	The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G0/G1 and Induces p21WAF1/CIP1/SDI1 in a p53-independent Manner 1997 ·Journal of Biological Chemistry ·Andreas Vogt, Jiazhi Sun, Yimin Qian, Andrew D. Hamilton, Saı̈d M. Sebti	160
16	Platelet-derived Growth Factor Receptor Tyrosine Phosphorylation Requires Protein Geranylgeranylation but not Farnesylation 1996 ·Journal of Biological Chemistry ·Terence F. McGuire, Yimin Qian, Andreas Vogt, Andrew D. Hamilton, Saı̈d Sebti	108
17	Ras CAAX Peptidomimetic FTI-277 Selectively Blocks Oncogenic Ras Signaling by Inducing Cytoplasmic Accumulation of Inactive Ras-Raf Complexes 1995 ·Journal of Biological Chemistry ·Edwina C. Lerner, Yimin Qian, Michelle A. Blaskovich, Renae D. Fossum, Andreas Vogt, Jiazhi Sun, Adrienne D. Cox, Channing J. Der, Andrew D. Hamilton, Saı̈d M. Sebti	314
18	A Non-peptide Mimetic of Ras-CAAX: Selective Inhibition of Farnesyltransferase and Ras Processing 1995 ·Journal of Biological Chemistry ·Andreas Vogt, Yimin Qian, Michelle A. Blaskovich, Renae D. Fossum, Andrew D. Hamilton, Saı̈d Sebti	95
19	Burkitt Lymphoma Daudi Cells Contain Two Distinct Farnesyltransferases with Different Divalent Cation Requirements 1995 ·Biochemistry ·Andreas Vogt, Jiazhi Sun, Yimin Qian, Elizabeth Tan-Chiu, Andrew D. Hamilton, Saı̈d M. Sebti	16
20	Mechanistic features associated with induction of metalloproteinases in human gingival fibroblasts by interleukin-1 1994 ·Archives of Oral Biology ·D.S. Tewari, Yimin Qian, Manu Tewari, (unknown), Ruth D. Thornton, Rebecca Taub, Eugene Mochan	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact